ASRT
Price
$0.63
Change
+$0.01 (+1.61%)
Updated
Jun 13 closing price
Capitalization
91.13M
47 days until earnings call
PAHC
Price
$23.93
Change
-$0.58 (-2.37%)
Updated
Jun 13 closing price
Capitalization
523.71M
74 days until earnings call
Interact to see
Advertisement

ASRT vs PAHC

Header iconASRT vs PAHC Comparison
Open Charts ASRT vs PAHCBanner chart's image
Assertio Holdings
Price$0.63
Change+$0.01 (+1.61%)
Volume$231.26K
Capitalization91.13M
Phibro Animal Health
Price$23.93
Change-$0.58 (-2.37%)
Volume$152.03K
Capitalization523.71M
ASRT vs PAHC Comparison Chart
Loading...
ASRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASRT vs. PAHC commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASRT is a Hold and PAHC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (ASRT: $0.63 vs. PAHC: $23.93)
Brand notoriety: ASRT and PAHC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ASRT: 83% vs. PAHC: 64%
Market capitalization -- ASRT: $91.13M vs. PAHC: $523.71M
ASRT [@Pharmaceuticals: Other] is valued at $91.13M. PAHC’s [@Pharmaceuticals: Other] market capitalization is $523.71M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASRT’s FA Score shows that 0 FA rating(s) are green whilePAHC’s FA Score has 1 green FA rating(s).

  • ASRT’s FA Score: 0 green, 5 red.
  • PAHC’s FA Score: 1 green, 4 red.
According to our system of comparison, PAHC is a better buy in the long-term than ASRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASRT’s TA Score shows that 5 TA indicator(s) are bullish while PAHC’s TA Score has 4 bullish TA indicator(s).

  • ASRT’s TA Score: 5 bullish, 5 bearish.
  • PAHC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ASRT is a better buy in the short-term than PAHC.

Price Growth

ASRT (@Pharmaceuticals: Other) experienced а -4.52% price change this week, while PAHC (@Pharmaceuticals: Other) price change was -0.62% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.40%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +66.97%.

Reported Earning Dates

ASRT is expected to report earnings on Jul 31, 2025.

PAHC is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.40% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PAHC($524M) has a higher market cap than ASRT($91.1M). PAHC has higher P/E ratio than ASRT: PAHC (34.11) vs ASRT (1.21). PAHC YTD gains are higher at: 15.091 vs. ASRT (-27.460). PAHC has higher annual earnings (EBITDA): 83.7M vs. ASRT (-222.9M). PAHC has more cash in the bank: 92.5M vs. ASRT (73.4M). ASRT has less debt than PAHC: ASRT (39.7M) vs PAHC (513M). PAHC has higher revenues than ASRT: PAHC (982M) vs ASRT (152M).
ASRTPAHCASRT / PAHC
Capitalization91.1M524M17%
EBITDA-222.9M83.7M-266%
Gain YTD-27.46015.091-182%
P/E Ratio1.2134.114%
Revenue152M982M15%
Total Cash73.4M92.5M79%
Total Debt39.7M513M8%
FUNDAMENTALS RATINGS
ASRT vs PAHC: Fundamental Ratings
ASRT
PAHC
OUTLOOK RATING
1..100
5820
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
23
Undervalued
PROFIT vs RISK RATING
1..100
10083
SMR RATING
1..100
9562
PRICE GROWTH RATING
1..100
6445
P/E GROWTH RATING
1..100
9892
SEASONALITY SCORE
1..100
44n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (23) in the Pharmaceuticals Major industry is somewhat better than the same rating for ASRT (79). This means that PAHC’s stock grew somewhat faster than ASRT’s over the last 12 months.

PAHC's Profit vs Risk Rating (83) in the Pharmaceuticals Major industry is in the same range as ASRT (100). This means that PAHC’s stock grew similarly to ASRT’s over the last 12 months.

PAHC's SMR Rating (62) in the Pharmaceuticals Major industry is somewhat better than the same rating for ASRT (95). This means that PAHC’s stock grew somewhat faster than ASRT’s over the last 12 months.

PAHC's Price Growth Rating (45) in the Pharmaceuticals Major industry is in the same range as ASRT (64). This means that PAHC’s stock grew similarly to ASRT’s over the last 12 months.

PAHC's P/E Growth Rating (92) in the Pharmaceuticals Major industry is in the same range as ASRT (98). This means that PAHC’s stock grew similarly to ASRT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASRTPAHC
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 27 days ago
80%
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 24 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 5 days ago
61%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ASRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COVTY34.440.20
+0.57%
Covestro AG
FGPHF0.02N/A
N/A
First Graphene Limited
WSPOF199.97-1.86
-0.92%
WSP Global Inc
ADMLF3.30-0.08
-2.23%
Adriatic Metals PLC
ESLOY138.95-3.79
-2.65%
EssilorLuxottica

ASRT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASRT has been loosely correlated with PAIOF. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ASRT jumps, then PAIOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASRT
1D Price
Change %
ASRT100%
+2.43%
PAIOF - ASRT
34%
Loosely correlated
N/A
RGEDF - ASRT
31%
Poorly correlated
N/A
OGI - ASRT
28%
Poorly correlated
-4.76%
AQST - ASRT
27%
Poorly correlated
+3.32%
SNOA - ASRT
27%
Poorly correlated
-2.22%
More

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with PBH. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then PBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
-2.37%
PBH - PAHC
48%
Loosely correlated
-1.37%
ZTS - PAHC
40%
Loosely correlated
-2.66%
ASRT - PAHC
39%
Loosely correlated
+2.43%
VTRS - PAHC
37%
Loosely correlated
-1.87%
ELAN - PAHC
37%
Loosely correlated
-2.54%
More